Measuring triamcinolone acetonide in aqueous humor by gas chromatography-electron-capture negative-ion mass spectrometry

被引:8
作者
Chu, Kai On
Ho, Thomas C.
Chiang, Wai Yee
Wang, Chi Chiu
Lam, Dennis Shun Chiu
Pang, Chi Pui
机构
[1] Chinese Univ Hong Kong, Hong Kong Eye Hosp, Dept Ophthalmol & Visual Sci, Kowloon, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2007年 / 847卷 / 02期
关键词
triamicinolone acetonide; aqueous humor; GC-NCI-MS;
D O I
10.1016/j.jchromb.2006.10.014
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Intravitreal triamcinolone acetonide (IVTA) injection has been used in the treatment of various posterior segment diseases. One of the side effects of IVTA is raised intraocular pressure, which may be secondary to triamcinolone acetonide (TAA)'s effects on the trabecular meshwork that affects aqueous outflow. In order to study the biological effects of TAA on the trabecular meshwork, we firstly need to reliably and accurately detect the concentration of TAA in tissue cells or fluids. In this study we have described a technique of using gas chromatography-electron-capture-negativeion mass spectrometry (GC-NCI-MS) to develop a simple, sensitive, selective and validated method to detect TAA in aqueous humor (AH) of rabbits following IVTA and subconjunctival TAA injections. We derivatized TAA from extracted aqueous sample by acetic anhydride and BSTFA, respectively, and analyzed by GC-NCI-MS. The detection limit was 0.3 ng/ml, linearity over 0.995 from 0 to 300 ng/ml. The reproducibility ranged from 10.4 to 3.9 for concentrations from 3 to 300 ng/ml, and recovery was over 95 % for the concentrations 10, 60, and 200 ng/ml. No interference was found from 159 aqueous samples. There was no TAA residue carried to the next injection from previously high concentration injection, 10,000 ng/ml. We have provided an alternative, rapid, and robust method other than LC-MS-MS for TAA detection in AH. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:199 / 204
页数:6
相关论文
共 19 条
[1]   Intravitreal triamcinolone for uveitic cystoid macular edema: An optical coherence tomography study [J].
Antcliff, RJ ;
Spalton, DJ ;
Stanford, MR ;
Graham, EM ;
Ffytche, TJ ;
Marshall, J .
OPHTHALMOLOGY, 2001, 108 (04) :765-772
[2]  
Antignac JP, 2000, RAPID COMMUN MASS SP, V14, P33, DOI 10.1002/(SICI)1097-0231(20000115)14:1<33::AID-RCM829>3.3.CO
[3]  
2-I
[4]   Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection [J].
Beer, PM ;
Bakri, SJ ;
Singh, RJ ;
Liu, WG ;
Peters, GB ;
Miller, M .
OPHTHALMOLOGY, 2003, 110 (04) :681-686
[5]   Determination of betamethasone and triamcinolone acetonide by GC-NCI-MS in excreta of treated animals and development of a fast oxidation procedure for derivatisation of corticosteroids [J].
Courtheyn, D ;
Vercammen, J ;
Logghe, M ;
Seghers, H ;
De Wasch, K ;
De Brabander, H .
ANALYST, 1998, 123 (12) :2409-2414
[6]  
Danis RP, 2000, RETINA-J RET VIT DIS, V20, P244, DOI 10.1097/00006982-200003000-00004
[7]   Measurement of low picomolar levels of triamcinolone acetonide in human bronchoalveolar lavage fluid by gas chromatography-electron-capture negative-ion mass spectrometry [J].
Hubbard, WC ;
Liu, MC ;
Bickel, C ;
Argenti, D ;
Heald, D ;
Schleimer, RP .
ANALYTICAL BIOCHEMISTRY, 2001, 290 (01) :18-25
[8]  
Jonas JB, 2003, ARCH OPHTHALMOL-CHIC, V121, P57
[9]   Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases [J].
Jonas, JB .
ACTA OPHTHALMOLOGICA SCANDINAVICA, 2005, 83 (06) :645-663
[10]   Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy [J].
Jonas, JB ;
Hayler, JK ;
Söfker, A ;
Panda-Jonas, S .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2001, 131 (04) :468-471